Health Care: Drugs

Protalix BioTherapeutics Inc (PLX: AMEX)

$0.93 n/a | n/a%
04/28/17 - 04:06 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 9.20M 4.36M 3.52M 0.00
Cost of Sales 5.85M 730.00K 630.00K 0.00
Gross Operating Profit 3.35M 3.63M 2.89M 0.00
Selling, General, and Administrative Expenses 9.36M 7.28M 9.23M 8.05M
Research & Development 24.61M 20.02M 22.22M 26.01M
Operating Income before D & A (EBITDA) -30.61M -23.67M -28.56M -34.06M
Depreciation & Amortization 2.55M 2.81M 3.58M 3.54M
Interest Income 589.00K 123.00K 196.00K 391.00K
Other Income - Net 14.06M 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -18.51M -26.36M -31.95M -37.21M
Interest Expense 10.66M 3.73M 4.93M 1.06M
Pre-Tax Income -29.18M -30.10M -36.88M -38.28M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -29.18M -27.28M -33.30M -34.74M
Net Income From Discontinued Operations -189.00K 85.32M 3.35M 6.95M
Net Income From Total Operations -29.36M 58.04M -29.94M -27.79M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -29.36M 58.04M -29.94M -27.79M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-29.18M -27.28M -33.30M -34.74M
Preferred Dividends
Net Income Available To Common -29.18M -27.28M -33.30M -34.74M
Basic EPS from Continuing Ops. -0.29 -0.29 -0.36 -0.38
Basic EPS from Discontinued Ops. 0.00 0.90 0.04 0.08
Basic EPS from Total Operations -0.29 0.61 -0.32 -0.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.29 0.61 -0.32 -0.30
Basic Normalized Net Income/Share -0.29 -0.29 -0.36 -0.38
EPS fr Continuing Ops. -0.29 -0.29 -0.36 -0.38
EPS fr Discontinued Ops 0.00 0.90 0.04 0.08
EPS fr Total Ops. -0.29 0.61 -0.32 -0.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.29 0.61 -0.32 -0.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.29 -0.29 -0.36 -0.38
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PLX

Latest PLX Headlines from TheStreet

More Financial News for PLX

Press Releases for PLX

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter